tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
with an average price target of $6.41. This is a potential upside of $4.87 (316.23%) from yesterday's end of day stock price of $1.54.
NGM Biopharmaceuticals's activity chart (see below) currently has 91 price targets and 61 ratings on display.
Analysts average stock forecasts to be materialized ratio is 45.14% with an average time for these price targets to be met of 144.5 days.
Most recent stock forecast was given by RITU BARAL from TD COWEN on 28-Feb-2024. First documented stock forecast 29-Apr-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1.55
$0.01 (0.65%)
$9
1 years 9 months 16 days ago
(28-Feb-2024)
4/6 (66.67%)
$0.02 (1.31%)
233
Buy
$1.55
$0.01 (0.65%)
$3.5
1 years 9 months 16 days ago
(28-Feb-2024)
1/3 (33.33%)
$0.02 (1.31%)
16
Buy
$3.5
$1.96 (127.27%)
$7
2 years 22 days ago
(22-Nov-2023)
3/9 (33.33%)
$2.79 (392.96%)
262
Buy
$6
$4.46 (289.61%)
$4
3 years 1 months 10 days ago
(04-Nov-2022)
2/8 (25%)
$0.64 (11.94%)
24
Buy
$4
$2.46 (159.74%)
$36
3 years 1 months 27 days ago
(17-Oct-2022)
4/6 (66.67%)
$0.59 (17.30%)
187
What is NGM (NGM Biopharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on NGM (NGM Biopharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NGM (NGM Biopharmaceuticals)?
Which analyst is the currently most bullish on NGM (NGM Biopharmaceuticals)?
Which analyst is the currently most reserved on NGM (NGM Biopharmaceuticals)?
